Diabetic Retinopathy: A Comprehensive Review of Pathogenesis and Clinical Management

Diabetic retinopathy is a leading cause of preventable vision loss globally, imposing significant socioeconomic burdens and escalating in prevalence parallel to the diabetes pandemic. The condition arises from a complex interplay of hyperglycaemia-induced vascular damage and neurodegeneration, driven by mechanisms involving oxidative stress, inflammation, and metabolic pathway dysregulation. The retina, with its accessible microvasculature, serves as a crucial indicator of broader systemic vascular health in diabetic patients, emphasizing the need for holistic management. Comprehensive management involves stringent control of blood glucose, blood pressure, and lipids, complemented by healthy lifestyle modifications. Regular, dilated eye examinations, adhering to established guidelines, are indispensable for early detection and timely intervention. Current therapeutic modalities, including laser photocoagulation, anti-VEGF intravitreal injections, and steroid implants, have significantly improved outcomes. Vitrectomy remains a vital surgical option for advanced complications. Future of Diabetic Retinopathy management is poised for transformative advancements, with promising research avenues in stem cell therapy, nanotechnology for targeted drug delivery, gene therapy to address underlying pathological pathways, and artificial intelligence for enhanced screening, diagnosis, and even prediction of systemic complications. These innovations aim to provide more effective, durable, and personalized treatment options, striving to preserve vision and improve quality of life for millions affected by diabetic retinopathy globally. This review delves into the multifaceted aspects of diabetic retinopathy, from its intricate pathogenesis to cutting-edge therapeutic advancements.